Skip to content
lsd.com

Indication

Metastatic Malignant Solid Neoplasm

3 registered trials testing Psilocybin for this indication, none currently recruiting.

3
Registered trials
0
Recruiting
0
In Phase 3

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Metastatic Malignant Solid Neoplasm trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 3 trials for Metastatic Malignant Solid Neoplasm

TrialStatusPhaseSubstanceSites
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic MalignanciesNCT07336238 · University of WashingtonActive, not recruitingPhase 2psilocybin1
Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic CancerNCT05847686 · University of WashingtonCompletedPhase 1 / Phase 2psilocybin1
A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic CancerNCT06644170 · University of WashingtonCompletedPhase 1psilocybin1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.